Fan Yang1, Tiange P Zhang2, Weiming Tang1, Jason J Ong3, Marcus Alexander4, Laura Forastiere5, Navin Kumar4, Katherine T Li6, Fei Zou7, Ligang Yang8, Guodong Mi9, Yehua Wang10, Wenting Huang10, Amy Lee10, Weizan Zhu11, Danyang Luo11, Peter Vickerman12, Dan Wu13, Bin Yang8, Nicholas A Christakis4, Joseph D Tucker14. 1. Dermatology Hospital of Southern Medical University, Guangzhou, China; University of North Carolina at Chapel Hill, Project-China, Guangzhou, China. 2. University of North Carolina at Chapel Hill, Project-China, Guangzhou, China; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. 3. Central Clinical School, Monash University, Melbourne, VIC, Australia; London School of Hygiene and Tropical Medicine, London, UK. 4. Yale Institute for Network Science, Yale University, New Haven, CT, USA. 5. Yale Institute for Network Science, Yale University, New Haven, CT, USA; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA. 6. University of North Carolina at Chapel Hill, Project-China, Guangzhou, China; Massachusetts General Hospital, Boston, MA, USA. 7. Department of Biostatistics, University of North Carolina at Chapel Hill, NC, USA. 8. Dermatology Hospital of Southern Medical University, Guangzhou, China. 9. Blued, Beijing, China. 10. University of North Carolina at Chapel Hill, Project-China, Guangzhou, China. 11. Zhitong Guangzhou LGBT Center, Guangzhou, China. 12. School of Social and Community Medicine, University of Bristol, Bristol, UK. 13. University of North Carolina at Chapel Hill, Project-China, Guangzhou, China; London School of Hygiene and Tropical Medicine, London, UK. 14. University of North Carolina at Chapel Hill, Project-China, Guangzhou, China; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: jdtucker@med.unc.edu.
Abstract
BACKGROUND: WHO recommends that men who have sex with men (MSM) receive gonorrhoea and chlamydia testing, but many evidence-based preventive services are unaffordable. The pay-it-forward strategy offers an individual a gift (eg, a test for sexually transmitted diseases) and then asks whether they would like to give a gift (eg, a future test) to another person. This study examined the effectiveness of a pay-it-forward programme to increase gonorrhoea and chlamydia testing among MSM in China. METHODS: We did a randomised controlled superiority trial at three HIV testing sites run by MSM community-based organisations in Guangzhou and Beijing, China. We included MSM aged 16 years or older who were seeking HIV testing and met indications for gonorrhoea and chlamydia testing. Restricted randomisation was done using computer-generated permuted blocks. 30 groups were randomised into three arms (1:1:1): a pay-it-forward arm in which men were offered free gonorrhoea and chlamydia testing and then asked whether they would like to donate for testing of prospective participants, a pay-what-you-want arm in which men were offered free testing and given the option to pay any desired amount for the test, and a standard-of-care arm in which testing was offered at ¥150 (US$22). There was no masking to arm assignment. The primary outcome was gonorrhoea and chlamydia test uptake ascertained by administrative records. We used generalised estimating equations to estimate intervention effects with one-sided 95% CIs and a prespecified superiority margin of 20%. The trial is registered with ClinicalTrials.gov, NCT03741725. FINDINGS: Between Dec 8, 2018, and Jan 19, 2019, 301 men were recruited and included in the analysis. 101 were randomly assigned to the pay-it-forward group, 100 to the pay-what-you-want group, and 100 to the standard-of-care group. Test uptake for gonorrhoea and chlamydia was 56% (57 of 101 participants) in the pay-it-forward arm, 46% (46 of 100 participants) in the pay-what-you-want arm, and 18% (18 of 100 participants) in the standard-of-care arm. The estimated difference in test uptake between the pay-it-forward and standard-of-care group was 38·4% (95% CI lower bound 28·4%). Among men in the pay-it-forward arm, 54 of 57 (95%) chose to donate to support testing for others. INTERPRETATION: The pay-it-forward strategy can increase gonorrhoea and chlamydia testing uptake among Chinese MSM and could be a useful tool for scaling up preventive services that carry a mandatory fee. FUNDING: US National Institute of Health; Special Programme for Research and Training in Tropical Diseases, sponsored by UNICEF, UNDP, World Bank, and WHO; the National Key Research and Development Program of China; Doris Duke Charitable Foundation; and Social Entrepreneurship to Spur Health.
BACKGROUND: WHO recommends that men who have sex with men (MSM) receive gonorrhoea and chlamydia testing, but many evidence-based preventive services are unaffordable. The pay-it-forward strategy offers an individual a gift (eg, a test for sexually transmitted diseases) and then asks whether they would like to give a gift (eg, a future test) to another person. This study examined the effectiveness of a pay-it-forward programme to increase gonorrhoea and chlamydia testing among MSM in China. METHODS: We did a randomised controlled superiority trial at three HIV testing sites run by MSM community-based organisations in Guangzhou and Beijing, China. We included MSM aged 16 years or older who were seeking HIV testing and met indications for gonorrhoea and chlamydia testing. Restricted randomisation was done using computer-generated permuted blocks. 30 groups were randomised into three arms (1:1:1): a pay-it-forward arm in which men were offered free gonorrhoea and chlamydia testing and then asked whether they would like to donate for testing of prospective participants, a pay-what-you-want arm in which men were offered free testing and given the option to pay any desired amount for the test, and a standard-of-care arm in which testing was offered at ¥150 (US$22). There was no masking to arm assignment. The primary outcome was gonorrhoea and chlamydia test uptake ascertained by administrative records. We used generalised estimating equations to estimate intervention effects with one-sided 95% CIs and a prespecified superiority margin of 20%. The trial is registered with ClinicalTrials.gov, NCT03741725. FINDINGS: Between Dec 8, 2018, and Jan 19, 2019, 301 men were recruited and included in the analysis. 101 were randomly assigned to the pay-it-forward group, 100 to the pay-what-you-want group, and 100 to the standard-of-care group. Test uptake for gonorrhoea and chlamydia was 56% (57 of 101 participants) in the pay-it-forward arm, 46% (46 of 100 participants) in the pay-what-you-want arm, and 18% (18 of 100 participants) in the standard-of-care arm. The estimated difference in test uptake between the pay-it-forward and standard-of-care group was 38·4% (95% CI lower bound 28·4%). Among men in the pay-it-forward arm, 54 of 57 (95%) chose to donate to support testing for others. INTERPRETATION: The pay-it-forward strategy can increase gonorrhoea and chlamydia testing uptake among Chinese MSM and could be a useful tool for scaling up preventive services that carry a mandatory fee. FUNDING: US National Institute of Health; Special Programme for Research and Training in Tropical Diseases, sponsored by UNICEF, UNDP, World Bank, and WHO; the National Key Research and Development Program of China; Doris Duke Charitable Foundation; and Social Entrepreneurship to Spur Health.
Authors: George W Pariyo; Elizabeth Ekirapa-Kiracho; Olico Okui; Mohammed Hafizur Rahman; Stefan Peterson; David M Bishai; Henry Lucas; David H Peters Journal: Int J Equity Health Date: 2009-11-12
Authors: Sheri A Lippman; Angela Donini; Juan Díaz; Magda Chinaglia; Arthur Reingold; Deanna Kerrigan Journal: Am J Public Health Date: 2009-09-17 Impact factor: 9.308
Authors: Grace M Lee; Jeanne M Santoli; Claire Hannan; Mark L Messonnier; James E Sabin; Donna Rusinak; Charlene Gay; Susan M Lett; Tracy A Lieu Journal: JAMA Date: 2007-08-08 Impact factor: 56.272
Authors: Tiange P Zhang; Fan Yang; Weiming Tang; Marcus Alexander; Laura Forastiere; Navin Kumar; Katherine Li; Fei Zou; Ligang Yang; Guodong Mi; Yehua Wang; Wenting Huang; Amy Lee; Weizan Zhu; Peter Vickerman; Dan Wu; Bin Yang; Nicholas A Christakis; Joseph D Tucker Journal: Infect Dis Poverty Date: 2019-08-16 Impact factor: 4.520
Authors: Anne Sung; Tiange P Zhang; Wenting Huang; Weiming Tang; Marcus Alexander; Laura Forastiere; Navin Kumar; Brian J Hall; Yusuf Ransome; Kevin D Dieckhaus; Dan Wu; Joseph D Tucker; Fan Yang Journal: Sex Transm Dis Date: 2022-06-08 Impact factor: 3.868
Authors: Eneyi Kpokiri; Elizabeth Chen; Jingjing Li; Sarah Payne; Priyanka Shrestha; Kaosar Afsana; Uche Amazigo; Phyllis Awor; Jean-Francois de Lavison; Saqif Khan; Jana D Mier-Alpaño; Alberto Ong; Shivani Subhedar; Isabelle Wachmuth; Kala M Mehta; Beatrice Halpaap; Joseph D Tucker Journal: medRxiv Date: 2020-11-04
Authors: Eneyi E Kpokiri; Elizabeth Chen; Jingjing Li; Sarah Payne; Priyanka Shrestha; Kaosar Afsana; Uche Amazigo; Phyllis Awor; Jean-Francois de Lavison; Saqif Khan; Jana Mier-Alpaño; Alberto Ong; Shivani Subhedar; Isabelle Wachmuth; Luis Gabriel Cuervo; Kala M Mehta; Beatrice Halpaap; Joseph D Tucker Journal: PLoS Med Date: 2021-09-13 Impact factor: 11.069
Authors: Elvin H Geng; Denis Nash; Nittaya Phanuphak; Kimberly Green; Sunil Solomon; Anna Grimsrud; Annette H Sohn; Kenneth H Mayer; Till Bärnighausen; Linda-Gail Bekker Journal: J Int AIDS Soc Date: 2022-04 Impact factor: 5.396